Form 8-K · Current report
McKesson Corporation 8-K, filed Oct 6, 2026
- Filed
- CIK
- 0000927653
- Accession no.
- 0000927653-26-000253
Summary
Clayton, Dubilier & Rice and McKesson Corporation have entered a definitive agreement to acquire Option Care Health, an independent home and alternate-site infusion services provider, for $32.05 per share, an enterprise value of about $5.8 billion. CD&R would hold a majority interest of roughly 51% and McKesson would invest about $1.4 billion for a minority interest of roughly 49%, with the transaction expected to close in the first half of 2027 subject to stockholder and regulatory approvals.
Key points
- The $32.05 per share price represents a premium of about 37% to Option Care Health's closing share price on October 5, 2026, the last full trading day before the announcement.
- Option Care Health will remain a separate company led by its own management team and would no longer be publicly listed on Nasdaq after closing.
- Option Care Health is withdrawing its previously disclosed financial guidance and will not host a live conference call for its third-quarter 2026 results, expected November 4, 2026.
- The transaction includes a framework for McKesson's future acquisition of CD&R's interest, subject to specified conditions and regulatory approvals.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure On October 6, 2026, McKesson Corporation (“Company”), Clayton, Dubilier & Rice, LLC (“CD&R”) and Option Care Health, Inc. issued a joint news release regarding a proposed acquisition of Option Care Health, Inc. A copy of that news release is posted on the Company’s website (https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/ and https://investor.mckesson.com/news/default.aspx) and attached hereto as Exhibit 99.1. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.